Frazier Healthcare Partners has acquired Altruix from WindRose Health Investors in a private equity transaction. Altruix, founded in 2005 and based in Hunt Valley, Maryland, operates as a behavioral health pharmacy platform serving patients with severe mental illness, substance use disorders, and intellectual and developmental disabilities.

Seattle-based Frazier Healthcare Partners, established in 1991, focuses on private equity investments across the healthcare sector. The firm targets substantial dollar investments and manages various investment strategies from company creation to buyouts of profitable lower-middle market companies. This acquisition aligns with Frazier's strategy of building specialized healthcare platforms.

New York's WindRose Health Investors, founded in 2000, has exited its position in Altruix after investing in the behavioral health pharmacy platform. WindRose typically invests across healthcare segments including outsourced services, technology-enabled solutions, providers, and distribution businesses. The firm's exit suggests potential returns from the behavioral health sector's growth.

Terms of the transaction were not disclosed, leaving the deal value unclear. However, the move signals continued private equity interest in specialized pharmacy services serving vulnerable populations. Behavioral health has become a focus area as healthcare systems seek specialized medication management for complex patient needs.